PDCD1 and neoplasm: The group treated with IS + 3CL-SH significantly improves the survival of mice bearing MC38 anti-PD-1-Resistant tumor model comparatively to the control group (p-value=0.00368, Log-rank Mantel-Cox test) (Figure 7C).